Eraña, H.; Charco, J.M.; González-Miranda, E.; García-Martínez, S.; López-Moreno, R.; Pérez-Castro, M.A.; Díaz-Domínguez, C.M.; García-Salvador, A.; Castilla, J.
Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases. Biomolecules 2020, 10, 469.
https://doi.org/10.3390/biom10030469
AMA Style
Eraña H, Charco JM, González-Miranda E, García-Martínez S, López-Moreno R, Pérez-Castro MA, Díaz-Domínguez CM, García-Salvador A, Castilla J.
Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases. Biomolecules. 2020; 10(3):469.
https://doi.org/10.3390/biom10030469
Chicago/Turabian Style
Eraña, Hasier, Jorge M. Charco, Ezequiel González-Miranda, Sandra García-Martínez, Rafael López-Moreno, Miguel A. Pérez-Castro, Carlos M. Díaz-Domínguez, Adrián García-Salvador, and Joaquín Castilla.
2020. "Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases" Biomolecules 10, no. 3: 469.
https://doi.org/10.3390/biom10030469
APA Style
Eraña, H., Charco, J. M., González-Miranda, E., García-Martínez, S., López-Moreno, R., Pérez-Castro, M. A., Díaz-Domínguez, C. M., García-Salvador, A., & Castilla, J.
(2020). Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases. Biomolecules, 10(3), 469.
https://doi.org/10.3390/biom10030469
